-
ALLO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Allogene Therapeutics (ALLO)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 61.53 mm | 61.53 mm | 61.53 mm | 61.53 mm | 61.53 mm | 61.53 mm |
Cash burn (monthly) | (no burn) | 8.63 mm | 23.92 mm | 24.12 mm | (no burn) | 12.87 mm |
Cash used (since last report) | n/a | 24.15 mm | 66.97 mm | 67.50 mm | n/a | 36.02 mm |
Cash remaining | n/a | 37.38 mm | -5.44 mm | -5.97 mm | n/a | 25.51 mm |
Runway (months of cash) | n/a | 4.3 | -0.2 | -0.2 | n/a | 2.0 |
13F holders | Current |
---|---|
Total holders | 175 |
Opened positions | 29 |
Closed positions | 16 |
Increased positions | 64 |
Reduced positions | 43 |
13F shares | Current |
---|---|
Total value | 368.18 bn |
Total shares | 201.31 mm |
Total puts | 111.60 k |
Total calls | 94.30 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
FMR | 31.26 mm | $72.83 bn |
PFE Pfizer | 22.03 mm | $103.33 mm |
TPG GP A | 18.72 mm | $43.61 bn |
BLK BlackRock | 16.45 mm | $38.32 bn |
Vanguard | 8.20 mm | $19.10 bn |
STT State Street | 7.67 mm | $17.87 bn |
Seaview Trust | 7.04 mm | $105.05 mm |
Capital World Investors | 6.90 mm | $16.07 bn |
T. Rowe Price | 5.79 mm | $13.49 mm |
Primecap Management | 5.67 mm | $13.21 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | Messemer Deborah M. | Common Stock | Sell | Dispose S | No | No | 2.18 | 9,136 | 19.92 k | 157,629 |
5 Dec 24 | Humer Franz B | Common Stock | Sell | Dispose S | No | No | 2.16 | 9,221 | 19.92 k | 307,507 |
21 Oct 24 | Parker Geoffrey M. | Common Stock | Payment of exercise | Dispose F | No | No | 2.84 | 36,404 | 103.39 k | 1,131,988 |
21 Aug 24 | Earl Martin Douglas | Common Stock | Payment of exercise | Dispose F | No | No | 2.785 | 28,310 | 78.84 k | 449,324 |
18 Jun 24 | Messemer Deborah M. | Common Stock | Sell | Dispose S | No | Yes | 2.2793 | 18,641 | 42.49 k | 166,765 |